biotech · WHIM Syndrome · Neutropenias · XFOR
X4 Pharmaceuticals
X4 Pharmaceuticals, Inc
X4 Pharmaceuticals clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 61 N Beacon St, Boston, Massachusetts 02134, US
- Founded
- 2014
- Employees
- 81
- Programs
- 11
- Drugs
- 6
- Patents
- 16
X4 Pharmaceuticals projects
11 ClinicalTrials.gov programs sponsored by X4 Pharmaceuticals.
X4 Pharmaceuticals has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Mavorixafor
X4 Pharmaceuticals, Inc
WHIM Syndrome
1 trial -
Mavorixafor
X4 Pharmaceuticals, Inc
Neutropenia
2 trials -
Mavorixafor, Mavorixafor Placebo Capsules
X4 Pharmaceuticals, Inc
Neutropenias
1 trial -
Mavorixafor, Placebo to Test IMP
X4 Pharmaceuticals, Inc
WHIM Syndrome
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
WHIM Syndrome
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
Clear Cell Renal Cell Carcinoma
2 trials -
Mavorixafor
X4 Pharmaceuticals, Inc
Hepatic Insufficiency
1 trial -
Mavorixafor
X4 Pharmaceuticals, Inc
Healthy Participants
1 trial -
Mavorixafor
X4 Pharmaceuticals, Inc
Waldenstrom's Macroglobulinemia
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
Healthy
1 trial -
X4P-001
X4 Pharmaceuticals, Inc
Melanoma
1 trial
Frequently asked questions
How many clinical projects does X4 Pharmaceuticals have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.